Survival and desferrioxamine in thalassaemia major. Issue 6322 (10th April 1982)

• Record Type: Journal Article
• Authors: Modell, B; Letsky, E A; Flynn, D M; Peto, R; Weatherall, D J
• Is Part Of: BMJ. Volume 284:Issue 6322(1982)
• Page Start: 1081
• Page End: 1084
• Publication Date: 1982-04-10
• Subjects: Medicine -- Periodicals; Medicine -- Periodicals; Medicine; Periodicals; 610
• DOI: 10.1136/bmj.284.6322.1081
• Languages: English
• ISSNs: 0007-1447

Abstract

Abstract : A small randomised trial and observation of all patients homozygous for beta-thalassaemia in Britain born in or before 1963 indicated that those patients who had received average weekly doses of more than 4 g of desferrioxamine over the previous few years were less likely to die in the near future than were patients of similar ages who had received less, or no, desferrioxamine.